William M. McClements, SVP of Corporate Operations at MERRIMACK PHARMACEUTICALS INC (MACK), bought 4,000 shares at $4.05 ($17K) on 2013-12-11, disclosed to the SEC on 2013-12-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.05 | 1,500 | $6K | 35.6% |
| 2 | $4.39 | 2,500 | $11K | 64.4% |
| Total | $4.26 avg | 4,000 | $17K | 100% |
| Filing → |
| MACK | BUY | 2013-12-02 | $25K | — | Filing → |